Development of accelerated high-throughput antiviral screening systems for emerging orthomyxoviruses.
Development of accelerated high-throughput antiviral screening systems for emerging orthomyxoviruses.
复制标题
DOI:
10.1016/j.antiviral.2022.105291
复制
发表时间:
2022-04
影响因子:
7.6
通讯作者:
中科院分区:
文献类型:
--
作者:
Bourbon virus (BRBV) is an emerging tick-borne orthomyxovirus that causes severe febrile illness in humans. There are no specific treatments for BRBV disease currently available. Here, we developed a highly accessible and robust, quantitative fluorescence-based BRBV minigenome (MG) system and applied it to high-throughput antiviral drug screening. We demonstrated that human dihydroorotate dehydrogenase (DHODH) inhibitors, hDHODH-IN-4 and brequinar, efficiently reduced BRBV RNA synthesis, and validated these findings using infectious BRBV in vitro. The DHODH inhibitors also exhibited high potency in inhibiting MG activities of other orthomyxoviruses with emerging zoonotic potential, including bat influenza A virus, swine influenza D virus, and Thogoto virus. Our newly developed MG system is a powerful platform for antiviral drug screening across the Orthomyxoviridae family, enabling rapid development and deployment of antivirals against future emerging orthomyxoviruses.
登录
查看更多内容
影响因子:
0.2
作者:
Bhatia HK;Singh H;Grewal N;Natt NK
通讯作者:
Natt NK
影响因子:
11.8
作者:
Ducatez, Mariette F.;Pelletier, Claire;Meyer, Gilles
通讯作者:
Meyer, Gilles
影响因子:
3.7
作者:
Hoenen, T.;Jung, S.;Becker, S.
通讯作者:
Becker, S.
DOI:
10.1292/jvms.16-0619
发表时间:
2017-08-18
期刊:
The Journal of veterinary medical science
影响因子:
--
作者:
Tsuda Y;Weisend C;Martellaro C;Feldmann F;Haddock E
通讯作者:
Haddock E
影响因子:
11.8
作者:
Kessell A;Hyatt A;Lehmann D;Shan S;Crameri S;Holmes C;Marsh G;Williams C;Tachedjian M;Yu M;Bingham J;Payne J;Lowther S;Wang J;Wang LF;Smith I
通讯作者:
Smith I